Brochure | August 19, 2021

Cleavage And Deprotection Systems To Enhance Production Safety And Efficiency

Our mid- to large-scale C&D Systems allow you to automate the cleavage and deprotection steps while increasing productivity by freeing up your oligosynthesizer to focus on its core job of synthesis.

Solid phase synthesis using flow-through columns has become the proven method for reliably producing antisense, RNAi and other therapeutic oligonucleotides by manufacturers. After synthesis, the oligo must be cleaved from the solid support and conditioned for further downstream processing.

To streamline and automate this overlooked unit operation, Asahi Kasei Bioprocess offers a family of Cleavage and Deprotection (C&D) Systems for your clinical- and commercialscale oligonucleotide manufacturing needs.

Available in flow rates starting at 180 L/h up to 2000 L/h, C&D Systems are designed to accommodate both DNA and RNA processes.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online